We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

37 hedge funds and large institutions have $36M invested in BioSpecifics Technologies Corp. in 2013 Q2 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
% of All Funds
1.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
37
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
BlackRock Advisors
Delaware
$12.8M +$13.2M +820,014 New
RG
2
Redmile Group
California
$4.87M +$5.02M +312,152 New
PI
3
Putnam Investments
Massachusetts
$4.23M +$4.36M +270,883 New
Franklin Resources
4
Franklin Resources
California
$2.64M +$2.72M +169,050 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.64M +$1.7M +105,387 New
RA
6
Royce & Associates
New York
$1.56M +$1.61M +100,000 New
Northern Trust
7
Northern Trust
Illinois
$1.06M +$1.09M +68,052 New
AC
8
Amici Capital
New York
$936K +$965K +60,000 New
MOACM
9
Mutual of America Capital Management
New York
$906K +$934K +58,059 New
DCM
10
DAFNA Capital Management
California
$806K +$832K +51,692 New
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$693K +$715K +44,417 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$380K +$392K +24,380 New
PP
13
Paloma Partners
Connecticut
$333K +$344K +21,365 New
First Manhattan
14
First Manhattan
New York
$328K +$322K +20,000 New
BCM
15
Bridgeway Capital Management
Texas
$311K +$321K +19,964 New
Goldman Sachs
16
Goldman Sachs
New York
$288K +$298K +18,493 New
Deutsche Bank
17
Deutsche Bank
Germany
$262K +$271K +16,841 New
Morgan Stanley
18
Morgan Stanley
New York
$255K +$263K +16,374 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$243K +$251K +15,600 New
BFA
20
BlackRock Fund Advisors
California
$228K +$236K +14,645 New
BJ
21
BlackRock Japan
Japan
$188K +$194K +12,069 New
LMF
22
LMR Master Fund
Cayman Islands
$181K +$187K +11,594 New
Bank of America
23
Bank of America
North Carolina
$157K +$162K +10,088 New
Wells Fargo
24
Wells Fargo
California
$152K +$157K +9,755 New
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$143K +$148K +9,171 New

BSTC Hedge Fund Activity: Q2 2013 in Review

37 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2013, worth a combined $36M.

Buyers outnumbered sellers: 37 funds opened new BSTC positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.

  • 37 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $36M of BioSpecifics Technologies Corp. stock for Q2 2013.
  • 37 funds opened new BioSpecifics Technologies Corp. positions in Q2 2013 and 0 closed out, a net change of +37 holders.

Based on aggregated 13F filings for Q2 2013.